Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers.

Publication ,  Journal Article
Vasquez, A; Gaínza-Lein, M; Sánchez Fernández, I; Abend, NS; Anderson, A; Brenton, JN; Carpenter, JL; Chapman, K; Clark, J; Gaillard, WD ...
Published in: Pediatr Neurol
September 2018

OBJECTIVE: We aimed to evaluate and compare the status epilepticus treatment pathways used by pediatric status epilepticus research group (pSERG) hospitals in the United States and the American Epilepsy Society (AES) status epilepticus guideline. METHODS: We undertook a descriptive analysis of recommended timing, dosing, and medication choices in 10 pSERG hospitals' status epilepticus treatment pathways. RESULTS: One pathway matched the timeline in the AES guideline; nine pathways described more rapid timings. All pathways matched the guideline's stabilization phase in timing and five suggested that first-line benzodiazepine (BZD) be administered within this period. For second-line therapy timing (initiation of a non-BZD antiepileptic drug within 20 to 40 minutes), one pathway matched the guideline; nine initiated the antiepileptic drug earlier (median 10 [range five to 15] minutes). Third-line therapy timings matched the AES guideline (40 minutes) in two pathways; eight suggested earlier timing (median 20 [range 15 to 30] minutes). The first-line BZD recommended in all hospitals was intravenous lorazepam; alternatives included intramuscular midazolam or rectal diazepam. In second-line therapy, nine pathways recommended fosphenytoin. For third-line therapy, eight pathways recommended additional boluses of second-line medications; most commonly phenobarbital. Two pathways suggested escalation to third-line medication; most commonly midazolam. We found variance in dosing for the following medications: midazolam as first-line therapy, fosphenytoin, and levetiracetam as second-line therapy, and phenobarbital as third-line therapy medications. CONCLUSIONS: The pSERG hospitals status epilepticus pathways are consistent with the AES status epilepticus guideline in regard to the choice of medications, but generally recommend more rapid escalation in therapy than the guideline.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatr Neurol

DOI

EISSN

1873-5150

Publication Date

September 2018

Volume

86

Start / End Page

33 / 41

Location

United States

Related Subject Headings

  • United States
  • Status Epilepticus
  • Societies, Medical
  • Practice Guidelines as Topic
  • Neurology & Neurosurgery
  • Infant
  • Humans
  • Hospitals, Pediatric
  • Hospitalization
  • Emergency Treatment
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vasquez, A., Gaínza-Lein, M., Sánchez Fernández, I., Abend, N. S., Anderson, A., Brenton, J. N., … Pediatric Status Epilepticus Research Group (pSERG), . (2018). Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers. Pediatr Neurol, 86, 33–41. https://doi.org/10.1016/j.pediatrneurol.2018.06.004
Vasquez, Alejandra, Marina Gaínza-Lein, Iván Sánchez Fernández, Nicholas S. Abend, Anne Anderson, J Nicholas Brenton, Jessica L. Carpenter, et al. “Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers.Pediatr Neurol 86 (September 2018): 33–41. https://doi.org/10.1016/j.pediatrneurol.2018.06.004.
Vasquez A, Gaínza-Lein M, Sánchez Fernández I, Abend NS, Anderson A, Brenton JN, et al. Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers. Pediatr Neurol. 2018 Sep;86:33–41.
Vasquez, Alejandra, et al. “Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers.Pediatr Neurol, vol. 86, Sept. 2018, pp. 33–41. Pubmed, doi:10.1016/j.pediatrneurol.2018.06.004.
Vasquez A, Gaínza-Lein M, Sánchez Fernández I, Abend NS, Anderson A, Brenton JN, Carpenter JL, Chapman K, Clark J, Gaillard WD, Glauser T, Goldstein J, Goodkin HP, Lai Y-C, Loddenkemper T, McDonough TL, Mikati MA, Nayak A, Payne E, Riviello J, Tchapyjnikov D, Topjian AA, Wainwright MS, Tasker RC, Pediatric Status Epilepticus Research Group (pSERG). Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers. Pediatr Neurol. 2018 Sep;86:33–41.
Journal cover image

Published In

Pediatr Neurol

DOI

EISSN

1873-5150

Publication Date

September 2018

Volume

86

Start / End Page

33 / 41

Location

United States

Related Subject Headings

  • United States
  • Status Epilepticus
  • Societies, Medical
  • Practice Guidelines as Topic
  • Neurology & Neurosurgery
  • Infant
  • Humans
  • Hospitals, Pediatric
  • Hospitalization
  • Emergency Treatment